The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.
Articles by Staff
How Physicians Can Break Into an Executive Position
To become an effective executive, physicians have to learn to be team players and be prepared that they may not always be the boss.
Letter: RA Approval for IL-1Ra
Investors convinced the executives of Synergen that they needed to evaluate IL-1Ra for a disease with a more rapid outcome. RA studies were too slow to yield a quick profit. Thus, they picked sepsis syndrome.
Arthritis in Winter
Fewer daylight hours impact both RA and OA
Prevalence of Gout and Hyperuricemia Increase in U.S.
Causes include sedentary lifestyle, an increased frequency of obesity and hypertension, diuretic use, and alcohol intake
Antiphospholipid Antibody Testing Update
Successes, challenges, and controversies of diagnostic methods for APS
New Year, New Faces
The Rheumatologist welcomes new editorial team
Data-Driven, Optimal Patient Care and Clinical Research
Expanded opportunities to advance rheumatology will be offered by ACR’s ongoing registry efforts
The Sexiness of Rheumatology
Finding the glamour in a humble field
Give Rheumatology Patients a Helping Hand
Nearly 10 million Americans suffer from carpal tunnel syndrome, a condition that disables a key nerve in the wrist resulting in numbness, tingling, weakness, and loss of function in the hands and wrist. These symptoms are similar to those of rheumatoid arthritis and other rheumatic conditions, and it is important that patients know the difference.
- « Previous Page
- 1
- …
- 58
- 59
- 60
- 61
- 62
- …
- 149
- Next Page »